CRISPR Therapeutics AG
Analysts predict CRSP shares will perform strongly in 2023
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or ...
JP Morgan gives an Overweight recommendation for CRISPR Therapeutics AG (CRSP)
CRISPR Therapeutics AG’s filing revealed that its Chief Financial Officer Prasad Raju unloaded Company’s shares for reported $1.79 million on ...
A company insider recently sold 10,000 shares of CRISPR Therapeutics AG [CRSP]. Should You also Consider to Sale?
CRISPR Therapeutics AG’s recent filing unveils that its Chief Financial Officer Prasad Raju unloaded Company’s shares for reported $0.56 million ...
CRSP’s latest rating updates from top analysts.
In a filing, CRISPR Therapeutics AG revealed its Chief Financial Officer Prasad Raju unloaded Company’s shares for reported $0.56 million ...
Examining the Potential Price Growth of CRISPR Therapeutics AG (CRSP)
In a filing, CRISPR Therapeutics AG revealed its Chief Executive Officer Kulkarni Samarth unloaded Company’s shares for reported $3.46 million ...
Understanding the Risks of Investing in CRISPR Therapeutics AG (CRSP)
CRISPR Therapeutics AG’s recent filing unveils that its Chief Executive Officer Kulkarni Samarth unloaded Company’s shares for reported $3.46 million ...
